Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
Bone Metastases
Brain Cancer
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Sarcomas/TGCT
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
More >>
OncLive TV: Celestia Higano, MD
<< Back to Our Featured Experts
Dr. Higano on the Effectiveness of PARP Inhibitors for Prostate Cancer
Dr. Higano on Changes Being Made in the Field of Prostate Cancer
Dr. Higano on Radium-223 for Prostate Cancer
Dr. Higano Discusses PARP Inhibitors in Prostate Cancer
Dr. Higano on Docetaxel for Hormone-Sensitive Prostate Cancer
Oncology Specialists
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Gregory E. Idos, MD
James K. McCloskey II, MD
Charles A. (Trey) Leath III, MD
Charles A. Leath III, MD
David H. Ilson, MD, PhD
Raghava R. Induru, MD
Jeffrey R. Infante, MD
Brant Inman, MD
George N. Ioannou, MD
Syma Iqbal, MD
Luisa Iruela-Arispe, PhD
Melinda L. Irwin, PhD
Claudine Isaacs, MD
Tim Iveson, MD, FACP
Toshiaki Iwase, MD
Hiroji Iwata, MD, PhD
Puneeth Iyengar, MD
Gopa Iyer, MD
Renuka Iyer, MD
OncLive News Network On Location: ASH 2019 Day 3
Trending Now
FDA Approves Generic Everolimus Tablets
Enasidenib Plus Azacitidine Significantly Improves Responses in Newly Diagnosed
IDH2
-Mutated AML
OncLive News Network On Location: ASH 2019 Day 1
OncLive News Network On Location: ASH 2019 Day 2
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x
Subscribe